Recent Updates
Recently added Catalysts
XTNT Positive Sentiment

Xtant Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Thursday, March 6, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Xtant Medical Holdings, Inc. reported a 28% revenue growth for the full year 2024. The company anticipates revenues between $126 million and $130 million for 2025 without requiring additional capital. This positive outlook reflects the company's strong performance in the medical technology sector.
Price reaction · baseline $0.4824 (2025-03-06 close) · hit after-hours · clean, no other XTNT news in the window
day 0 close
-4.4%
day 1
-9.2%
day 3
+1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Full Year 2024 revenue growth of 28%.
  • Projected revenue for 2025 is between $126 million and $130 million.
  • No need for additional capital to achieve projected revenue.

Full Press Release Details

Full Year 2024 Revenue Growth of 28% Expects 2025 Revenue of $126 Million to $130 Million Without Need for Additional Capital BELGRADE, MT / ACCESS Newswire / March 6, 2025 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for

Frequently Asked Questions

What was Xtant Medical's revenue growth for 2024?

Xtant Medical reported a revenue growth of 28% for the full year 2024.

What revenue does Xtant Medical expect for 2025?

Xtant Medical expects revenue between $126 million and $130 million for 2025.

Will Xtant Medical need additional capital for 2025?

No, Xtant Medical does not anticipate needing additional capital for 2025.

ShareAdd on Google
Tags: XTNT Viatris Investor Conferences Healthcare Xtant Medical 2024 financial results revenue growth medical technology
Last updated: Mar 6, 2025

Biotech snapshot

Cash runway
$10M liquidity · $2M/mo burn
~4 mo
High dilution risk